How Will the Management of HIVHCVCoinfected Patien
Clinical Care Options HIV - Vi



Highlights of the 12th International Workshop on A
Clinical Care Options HIV - Vi



Updates From the 1st International Workshop on HIV
Clinical Care Options HIV - Vi



Identifying a Broadly Neutralizing HIV1 Antibody
Clinical Care Options HIV - Vi



Whats New in Tropism Testing
Clinical Care Options HIV - Vi



Update on Genotypic Assays for Integrase and CCR5
Clinical Care Options HIV - Vi



Implications of New Data on Complications Associat
Clinical Care Options HIV - Vi



Neurocognitive Dysfunction in HIVInfected Patients
Clinical Care Options HIV - Vi



Impact of Early Testing and Treatment
Clinical Care Options HIV - Vi



Update on Current State of PreExposure Prophylaxis
Clinical Care Options HIV - Vi



What to Start in a TreatmentNaive Patient With Tra
Clinical Care Options HIV - Vi



Results From the Thai Vaccine Trial
Clinical Care Options HIV - Vi



Updated DHHS Guidelines on When to Start Antiretro
Clinical Care Options HIV - Vi



The Role of Maraviroc in Firstline Therapy
Clinical Care Options HIV - Vi



Final Results From ACTG 5202
Clinical Care Options HIV - Vi



Antiretroviral Therapy for HIVInfected Pregnant Pa
Clinical Care Options HIV - Vi



Effect of Smoking and Recreational Drugs on Antire
Clinical Care Options HIV - Vi



Race and Response to Antiretroviral Therapy
Clinical Care Options HIV - Vi



Investigational Agents at ICAAC 2009
Clinical Care Options HIV - Vi



New RealTime PCR Viral Load Assays
Clinical Care Options HIV - Vi



Joseph J. Eron Jr. MD Expert Highlight New Agents
Clinical Care Options HIV - Vi



Joel E. Gallant MD MPH Expert Highlight Timing an
Clinical Care Options HIV - Vi



Daniel R. Kuritzkes MD Expert Highlight Antiretro
Clinical Care Options HIV - Vi



Sharon L. Walmsley MSc MD FRCPC Expert Highlight
Clinical Care Options HIV - Vi



Update on the Management of TreatmentExperienced P
Clinical Care Options HIV - Vi



Report on Abacavir Safety and Efficacy From IAC 20
Clinical Care Options HIV - Vi



Initiating Antiretroviral Therapy in TBHIVCoinfect
Clinical Care Options HIV - Vi



A Review of the EACS and BHIVA Antiretroviral Trea
Clinical Care Options HIV - Vi



Markers of Inflammation in Atherosclerosis for Pat
Clinical Care Options HIV - Vi



Expert Highlight Late Breaker Sessions Daniel R.
Clinical Care Options HIV - Vi



Expert Highlight Women and HIV Kathleen E. Squire
Clinical Care Options HIV - Vi



Expert Highlight Poster Recap Pedro Cahn MD PhD
Clinical Care Options HIV - Vi



Expert Highlight Newer Antiretrovirals Kimberly Y
Clinical Care Options HIV - Vi



Update on Adherence 2008
Clinical Care Options HIV - Vi




Clinical Care Options HIV - Vi



Kimberly Smith MD MPH When to Start Antiretroviral
Clinical Care Options HIV - Vi



CCO Independent Report From the 2008 International
Clinical Care Options HIV - Vi



Treatment Considerations for a Highly TreatmentExp
Clinical Care Options HIV - Vi



Management of an AntiretroviralExperienced Patient
Clinical Care Options HIV - Vi



Management of an HIVInfected Female With Dyslipide
Clinical Care Options HIV - Vi



Making Treatment Decisions for a Chronically Ill P
Clinical Care Options HIV - Vi



Selecting an Antiretroviral Regimen for a Woman Re
Clinical Care Options HIV - Vi



Recent Advances in PI Therapy
Clinical Care Options HIV - Vi



Interpreting Antiretroviral Pharmacokinetic Data f
Clinical Care Options HIV - Vi



Use of New Agents in a Patient With Limited Treatm
Clinical Care Options HIV - Vi



How Many Agents Does a TreatmentExperienced Patien
Clinical Care Options HIV - Vi



HIV Coreceptor Usage and Treatment Progression
Clinical Care Options HIV - Vi



New Data on Abacavir and Implications for Treatmen
Clinical Care Options HIV - Vi



New Drugs in Clinical Practice Update From Boston
Clinical Care Options HIV - Vi



Management of a MultidrugResistant Patient
Clinical Care Options HIV - Vi